Vaccinex, Inc. (VCNX)
OTCMKTS · Delayed Price · Currency is USD
1.000
-0.040 (-3.85%)
At close: Apr 9, 2026
Vaccinex Market Cap
Vaccinex has a market cap or net worth of $2.68 million as of April 10, 2026. Its market cap has decreased by -9.09% in one year.
Market Cap
2.68M
Enterprise Value
3.26M
Revenue
601.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.00
Market Cap Chart
Since August 9, 2018, Vaccinex's market cap has decreased from 130.58M to 2.68M, a decrease of -97.95%. That is a compound annual growth rate of -39.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 2.68M | -7.02% |
| Dec 31, 2025 | 2.88M | 9.74% |
| Dec 31, 2024 | 2.62M | -68.42% |
| Dec 29, 2023 | 8.31M | -74.16% |
| Dec 30, 2022 | 32.15M | 0.35% |
| Dec 31, 2021 | 32.03M | -30.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomind Labs | 4.34M |
| AccuStem Sciences | 4.26M |
| GPL Holdings | 4.17M |
| Oncology Pharma | 3.87M |
| Galera Therapeutics | 3.13M |
| CASI Pharmaceuticals | 2.97M |
| Burzynski Research Institute | 2.76M |
| VitaSpring Biomedical | 2.30M |